Abiopharma

🔍 Klein Michael Stuart (Director)

Company: Claritev Corp (CTEV)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 8,977 shares of Class A common stock (Direct)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 24,334.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A common stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: See note | shares_owned_after: 195,490.00 | Footnotes: F2, F3

Footnotes:

• F1: Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata based on the number of days of service provided to the issuer in the event of a voluntary resignation other than when grounds for termination for cause exist.
• F2: Includes shares of Class A common stock directly held by M. Klein Associates, Inc. and another entity for which the Reporting Person serves as the managing member.
• F3: The Reporting Person is the controlling stockholder of M. Klein Associates, Inc. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of any securities reported herein. The Reporting Person disclaims beneficial ownership of any securities of the Issuer except to the extent of the Reporting Person's pecuniary interest therein.